BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 487265)

  • 1. Effect of isoproterenol on phosphorylase activation in the hyperthyroid rat heart.
    Longhurst PA; McNeill JH
    Can J Physiol Pharmacol; 1979 Jun; 57(6):567-73. PubMed ID: 487265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of enhanced phosphorylase activation in the hyperthyroid rat heart.
    Werth DK; Watanabe AM; Hathaway DR
    J Mol Cell Cardiol; 1983 Mar; 15(3):163-71. PubMed ID: 6306261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced contractile response and protein kinase activation to threshold levels of beta-adrenergic stimulation in hyperthyroid rat heart.
    Guarnieri T; Filburn CR; Beard ES; Lakatta EG
    J Clin Invest; 1980 Apr; 65(4):861-8. PubMed ID: 6102099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of calcium oncardiac phosphorylase activation, contractile force and cyclic AMP in euthyroid and hyperthyroid rat hearts.
    Hartley EJ; McNeill JH
    Can J Physiol Pharmacol; 1976 Aug; 54(4):590-5. PubMed ID: 184894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the cardiac phosphorylase activating effect of dibutyryl cyclic AMP by thyroid hormone.
    McNeill JH
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):735-43. PubMed ID: 193168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cholinergic antagonism of the effects of isoproterenol on hearts from hyperthyroid rats.
    Watanabe AM; Hathaway DR; Besch HR
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 11():423-9. PubMed ID: 201993
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of experimental diabetes on rat cardiac cAMP, phosphorylase, and inotropy.
    Vadlamudi RV; McNeill JH
    Am J Physiol; 1983 Jun; 244(6):H844-51. PubMed ID: 6305213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of isoproterenol on isolated heart preparations from normal and hyperthyroid rats.
    Longhurst PA; McNeill JH
    Proc West Pharmacol Soc; 1979; 22():415-8. PubMed ID: 515079
    [No Abstract]   [Full Text] [Related]  

  • 9. Formation of partially phosphorylated phosphorylase in isoproterenol stimulated rat hearts.
    Vereb G; Szücs K; Szabó J; Belanova M; Bot G
    Mol Cell Biochem; 1986 Feb; 69(2):139-46. PubMed ID: 3083238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate dependence of isoproterenol-stimulated phosphorylase a formation in mouse heart.
    Barovsky K; Gross SR
    J Pharmacol Exp Ther; 1981 May; 217(2):326-32. PubMed ID: 6262483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hypoxia and catecholamine stimulation on cardiac performance in the isolated working hyperthyroid rat heart.
    Butkow N; Marcus RH; Wheatley AM
    Arch Int Pharmacodyn Ther; 1991; 311():46-56. PubMed ID: 1789713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thyroxine pretreatment and calcium on the isolated perfused rat heart.
    Aronson CE
    Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):180-9. PubMed ID: 962434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced cAMP levels and glycogen phosphorylase activation in isoproterenol perfused SHR myocardium.
    Sharma RV; Gupta RC; Ramanadham M; Venema RC; Bhalla RC
    Basic Res Cardiol; 1983; 78(6):695-705. PubMed ID: 6318720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of altered thyroid state on the inotropic potency of isoproterenol--studies with isolated rat left atria paced at different frequencies.
    Handberg GM
    J Cardiovasc Pharmacol; 1984; 6(5):943-8. PubMed ID: 6209504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of desmethylimipramine on the action of thyroxine on cardiac beta-receptors and myocardial phosphorylase.
    Hess ME; Reynolds KA; Frazer A; Viscusi D
    J Cardiovasc Pharmacol; 1980; 2(6):867-79. PubMed ID: 6160335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of verapamil on myocardial contractility, cardiac adenosine 3,'5'-monophosphate and heart phosphorylase.
    Shanfeld J; Hess ME; Levine NR
    J Pharmacol Exp Ther; 1975 May; 193(2):317-26. PubMed ID: 167148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone-induced supersensitivity to the cardiac phosphorylase-activating effect of adrenergic amines.
    McNeill JH
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 11():413-8. PubMed ID: 201991
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of dibutyryl cyclic AMP on cardiac phosphorylase a activity in euthyroid and hyperthyroid hearts.
    McNeill JH
    Proc West Pharmacol Soc; 1977; 20():405-8. PubMed ID: 197545
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of dobutamine on rat cardiac cyclic AMP, phosphorylase a and force of contraction.
    McNeill JH
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):597-600. PubMed ID: 209506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of adenosine inhibition of catecholamine-induced responses in heart.
    Dobson JG
    Circ Res; 1983 Feb; 52(2):151-60. PubMed ID: 6297829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.